Article
Thermo Fisher's COVID-19 Test Could Have Inaccurate Results
Rating:
0.0
Views:
63
Likes:
1
Library:
1
FDA warned earlier this week that Thermo Fisher Scientific's TaqPath test could have a risk of false results. This follows the Waltham, MA-based company exiting its bid to acquire Qiagen for $12.5 billion.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value